A DIR is a dealing involving the intentional release of GMOs. A DIR licence issued by the Regulator sets out the conditions under which such dealings must be done. Find out how to apply for a DIR licence.
This Statement of Intent outlines the activities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) over the next 3 years from 2023 to 2026.
People and organisations wishing to work with Genetically Modified Organisms (GMOs) have been able to do so provided they follow laws designed to protect people and the environment.
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR).
The report describes the roles and responsibilities of the Gene Technology Regulator (Regulator) and the OGTR. It provides a picture of the OGTR’s performance over the past 12 months.
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the OGTR during 2016-17.
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2018-19.
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2019-20.
The purpose of this document is to inform researchers undertaking NLRDs about the Gene Technology Regulator’s (the Regulator’s) operational policy for considering requests to conduct NLRDs in alternate facilities, pursuant to regulation 13(2)(c).
This document provides guidance to licence holders/applicants on the OGTR’s policy in relation to licensing for commercial release1 of genetically modified (GM) plants produced by conventional breeding (‘stacking’) between different, separately licensed, plant genetically modified organisms (GMOs).